ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,155,885 | -53.5% | 4,360,807 | -16.6% | 0.00% | -66.7% |
| Q2 2023 | $49,803,866 | +25.3% | 5,226,009 | +44.6% | 0.00% | +50.0% |
| Q1 2023 | $39,762,591 | -63.5% | 3,614,781 | -50.9% | 0.00% | -33.3% |
| Q4 2022 | $108,909,796 | +114.6% | 7,358,770 | +177.1% | 0.00% | 0.0% |
| Q3 2022 | $50,742,000 | +70.5% | 2,655,235 | +90.1% | 0.00% | +50.0% |
| Q2 2022 | $29,758,000 | +29.9% | 1,396,425 | +17.4% | 0.00% | +100.0% |
| Q1 2022 | $22,910,000 | -1.4% | 1,189,500 | +6.2% | 0.00% | 0.0% |
| Q4 2021 | $23,235,000 | -6.4% | 1,120,306 | +7.8% | 0.00% | 0.0% |
| Q3 2021 | $24,827,000 | -21.1% | 1,039,213 | -9.8% | 0.00% | -50.0% |
| Q2 2021 | $31,451,000 | +12.3% | 1,152,482 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $28,004,000 | +18.7% | 967,982 | +15.4% | 0.00% | +100.0% |
| Q4 2020 | $23,602,000 | +203.5% | 839,022 | +216.1% | 0.00% | 0.0% |
| Q3 2020 | $7,777,000 | +37.8% | 265,434 | +42.3% | 0.00% | – |
| Q2 2020 | $5,642,000 | +13.0% | 186,580 | +11.4% | 0.00% | – |
| Q1 2020 | $4,993,000 | – | 167,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |